Antimicrobial Agents and Chemotherapy · 2011 · 25 citations · 17 references
Public HealthClinical PharmacokineticsPharmacokineticsHiv ControlHiv PreventionSalivary DiagnosticsAntiretroviral TherapyAntiviral TherapyPost-exposure ProphylaxisPre-exposure ProphylaxisPrevention Of Sexual TransmissionTreatment As PreventionHiv Postexposure ProphylaxisHiv Pre-exposure ProphylaxisHiv Preexposure ProphylaxisPharmacokinetics Of Antiretroviral DrugsPharmacokinetics Of Prevention DrugsSalivary Drug MonitoringTenofovir TherapyTenofovir-based Prophylaxis
To prevent acquisition of HIV through oral sex, drugs used for preexposure prophylaxis (Prep) need to diffuse in saliva. We measured tenofovir (TFV) and emtricitabine (FTC) concentrations simultaneously in the plasma and saliva of 41 HIV-infected patients under stable antiretroviral treatment. Mean ratios of saliva/plasma concentration were 3% (±4%) and 86.9% (±124%) for TFV and FTC, respectively. Tenofovir disoproxil fumarate (TDF) should be used in combination with FTC to prevent oral acquisition of HIV.
17
Sihem Benaboud, Alain Pruvost, Patrick Coffié et al. · Antimicrobial Agents and Chemotherapy · 2010 · 138 citations